AbstrAct: Glioblastoma multiforme is the most aggressive type of glioma and the most common malignant primary intraaxial brain tumor. In an effort to predict the evolution of the disease and optimize therapeutical decisions, several models have been proposed for simulating the growth pattern of glioma. One of the latest models incorporates cell proliferation and invasion, angiogenic net rates, oxygen consumption, and vasculature. These factors, particularly oxygenation levels, are considered fundamental factors of tumor heterogeneity and compartmentalization. This paper focuses on the initializa tion of the cancer cell populations and vasculature based on imaging examinations of the patient and presents a feasibility study on vasculature prediction over time. To this end, pharmacokinetic parameters derived from dynamic contrastenhanced magnetic resonance imaging using Toft's model are used in order to feed the model. K trans is used as a metric of the density of endothelial cells (vasculature); at the same time, it also helps to discriminate distinct image areas of interest, under a set of assumptions. Feasibility results of applying the model to a real clinical case are presented, including a study on the effect of certain parameters on the pattern of the simulated tumor.
Introduction
Gliomas are one of the most common tumors that originate in the central nervous system (CNS). They derive most plau sibly from multipotent progenitor cells, showing histological features similar to astrocytes or oligodendroglial cells, 1 and develop usually near the vascular niches. 2, 3 Glioblastoma multiforme (GBM) is the most aggressive type of glioma, classified as grade IV by the World Health Organization. 4, 5 The main characteristics of GBM include cellular polymor phism, brisk mitotic activity, microvascular proliferation, necrosis, 6 high degree of invasiveness, and infiltrative edema. Particularly for edema, white matter surrounding the lesion is edematogenous; edema consists mainly of infiltrating tumor cells and a lesser proportion of vasculature. 7, 8 Despite a multi modal treatment strategy and extensive research on possible new treatment approaches during the last decades, mortality has not changed significantly, with average life expectancy ranging between 12 and 15 months. 6, 9 Cancer cells in solid tumors form a mass with augmented metabolic needs due to constant, vigorous changes. As the solid tumor develops, it must generate its own blood supply due to insufficient diffusion of nutrients and oxygen from preexisting vasculature. GBM is a highly vascularized tumor, recruiting preexisting vessels of an already welloxygenated organ like brain and generating neovasculature from excessive levels of circulating vascular endothelial growth factor (VEGF) apart from other proangiogenic molecules. 10 Intratumoral hypoxia is considered to be the main driving force of induced angio genesis within the tumor, in agreement with Folkman's asser tion. 11 Hypoxiainducible factor (HIF1α) is a transcription factor that promotes ischemiadriven angiogenesis through the induction of differential expression of VEGF. VEGF appears to be a key molecule for both the proangiogenic events and the survival of newly formed vessels. 12 At a cellular/ tissue level, the series of events is a multistep, repeatable pro cess. In brief, first, the preexisting neighboring vessels stretch and expand toward tumor as a response to the proangiogenic factors released by cancer cells. The new endothelial cells migrate in a concrete way while degrading concurrently the extracellular matrix, and eventually form tube structures. [13] [14] [15] However, the mechanisms of angiogenesis in tumors fail to promote mature vascular networks and lead to the formation of abnormal, leaky, tortuous, and/or shunt vessels, 16 which fail to restore oxygen supply in hypoxic regions, which further induces HIF expression and a perpetual cycle of events from hypoxia and HIF1α expression to VEGF, angiogenesis, and tumor growth.
A Proposed Paradigm Shift in Initializing Cancer Predictive Models with DCE-MRI Based
The extreme invasive and neoplastic growth of GBM has motivated the development of mathematical models for augmenting the understanding of the mechanism of glioma growth and predicting the temporal evolution of growth and therapy response. A number of different mathemati cal models have been proposed, allowing the description of tumor growth and invasion at different spatiotemporal scales. 17, 18 Among them, discrete mathematical models describe tumor cells as individual entities and study how their microinteractions affect tumor behavior and morpho logy, 19 while continuum approaches are better in describing tumors at tissue level assuming that tumor cells can be rep resented by densities or volume fractions. [20] [21] [22] [23] [24] [25] More recently, the incorporation of patientspecific, noninvasive imaging data to the existing mathematical approaches seems to be critical for the validation and clinical translation of such models, which is evident by the growing interest in this direction. 26, 27 Magnetic resonance imaging (MRI) is used for the esti mation of tumor size, borders, and vasculature. Dynamic contrastenhanced MRI (DCEMRI) is a technique where MRI sequences are obtained before, during, and after the intravenous administration of a low molecular weight gado linium (Gd) chelate contrast agent. DCEMRI data can later be processed using Toft's model (TM) 28 in order to evaluate pharmacokinetic (PK) parameters that are able to quantify the differential leakage during the pass of the tracer's bolus in the tumor compartment of the model. DCEMRI is frequently applied in brain oncology because of the prominence of vascu lature that characterizes these tumors.
Several approaches attempting to decode cancer physi ology through imaging biomarkers and use them toward initializing computational models with clinical data have recently emerged. Swanson et al. 29 utilized two pretreat ment time points of Gdenhanced, T1weighted (T1Gd) and T2weighted (T2) volume data to derive the micro scopic tumor growth parameters of invasion and prolifera tion. Ellingson et al. 30 proposed a method of using serial diffusionweighted MR (DWMRI) images in order to estimate the same microscopic parameters. Szeto et al. 31, 32 combined MRI and positron emission tomography (PET) images from GBM cases to show that tumor aggressiveness estimated by a reactiondiffusion equation and MRI data is correlated with hypoxic burden visible on fluoromisonida zole (FMISO)PET. Recently Yankeelov et al. 26, 33 empha sized the importance of having a direct relevance to clinical outcome using both diffusion and perfusion MRI for param eterizing a logistic growth model and predicting chemother apy effect and cellularity in breast cancer. They used serial apparent diffusion coefficient measurements to estimate the tumor cell population and approximate the proliferation rate of tumor cells. An extended TM (ETM) was used in their work in order to incorporate the v e and v p PK parameters into the estimation of tumor cell number. 33 However, none of the above has made an effort or presented a framework to predict vascularity macroscopically based on imaging studies and predictive models.
In this work, we focus on translating anatomical infor mation and functional imaging biomarkers derived from DCEMRI into tumor characteristics in order to set the initial state of glioma growth models with perspectives on clinical outcome. Our central objective is to demonstrate the feasibility to predict vascularity changes over time under the assumption that the PK parameter K trans well characterizes the vasculature in each imaging session. This assumption is based on published clinical studies where it is reported that determination of tracer kinetics by K trans is a primary marker for monitoring vascular and angiogenic treatment effect. 34 We propose a method based on DCEMRI in order to initialize an extended mathematical model 35, 36 that describes the spa tiotemporal evolution of tumor cells and their microenviron ment. The model incorporates three types of cell populations (normoxic, hypoxic, and necrotic), endothelial cells (building vasculature), angiogenic factors, and oxygen concentration. The interactions among the different species are described using a system of coupled partial differential equations. DCE MRI is used for extracting PK information and particularly K trans , which is then used for (1) guiding tumor's compart ment (viable cells and necrosis) selection within the region of interest (ROI) and (2) setting up the initial map of the vasculature. 36, 37 To our knowledge, this is the first attempt of a glioma model initialization and validation based on the parametric map. The methodology proposed is subsequently applied to a real clinical case where the followup (FU) imag ing examination is used as the gold standard for assessing vasculature prediction. The simulated tumor vasculature is correlated with the real tumor evolution, and the effect of certain model parameters is also examined.
Methods
In this work, we mainly address the question of whether the evolution of tumor vascularity can be predicted (through the integration of medical imaging and computational model ing). To elaborate on this, we first chose a welldeveloped tumor growth computational model that accounts for vascu lature evolution. 36 Then, through DCEMRI patient data, we incorporated spatial information of the initial vasculature into the model in the least possible arbitrary way. Although numerous research studies have been focused on tumor vas cularization, 36, [38] [39] [40] [41] to our knowledge, this is the first attempt where the vasculature estimated by clinical MRI data is intro duced to initialize a computational model of tumor growth. DCEMRI, routinely used by clinicians, is used to extract tumor physiology information through PK model analysis. For this reason, we fitted TM, which converts Gd concentra tion time curves into the more informative PK parameters. In fact, the properties of K trans , the PK parameter that we used, depend on the model used to calculate it. TM not only is the most common model for such estimations but also, as shown in comparative studies, is the best in terms of fitting errors and ambiguity compared to other more complex ana lytical models. 42 Among the variables that are evaluated by TM, we chose K trans because it is indicative of vascular per meability, and also depends on surface area and blood vol ume and flow. 43, 44 The following sections explain our method in detail.
PK dce-MrI parameters. Perfusion DCEMRI may characterize the rate of delivery of nutrients via blood into brain tissue parenchyma. The maps that are constructed through the analysis of such data reveal microvasculature information, which can be correlated to the levels of angio genesis and the grade of the tumor. DCEMRI is performed by acquiring T1weighted images before, during, and after the intravenous injection of a low molecular weight Gd chelate, which enters the blood circulation and is deposited on the tis sue without entering the cells. Due to the disruption of the blood-brain barrier (BBB), tumor sites show a faster and more acute development than healthy background tissue, followed by deamplification after repletion of the available space. 45 The boosted infiltration and vascularization of tumor lesions leads to enhanced permeability of contrast agents in blood vessels supplying the tumor, which results in corresponding "bright" image regions in the postcontrast phase during image acqui sition. Afterwards, the Gd tracer evacuates the tissue with reentry to the vessels.
The concentration of the contrast agent, along with other parameters such as the transport rate constants, is measured when passing through the vessels to the extracellular space, and vice versa. DCEMRI is used for the calculation of the vascular permeability constants through PK models and is a useful tool for characterizing tumor blood vessels and differ ent compartments of the affected tissue.
This work uses TM 28 in order to quantify the permeability of the vessels by the measurement of K trans (min -1 ), the transfer constant between blood plasma and extravascular-extracellular space (EES), which is indicative of the volume of blood that flows out of the vessels; u e , the volume of EES per unit volume of tissue, which represents the volume of blood which flows out of the vessels; and k ep , the rate constant between EES and blood plasma (min -1 ). DCEMRI PK parameters, which reflect the physiology of the tumor, are used to obtain a more realistic estimation of the model's initial parameters and set their default bounds. The precise set of values is patientspe cific since they depend on a DCEMR image referring to a particular brain tumor.
Based on DCEMRI, we can estimate the vascular per meability constants for an agent driven effectively through the blood vessels. Moreover, though Gd passes through the endothelium of the blood vessels, it cannot pass through the cancer cells and, thus, it remains in the EES until its resorp tion. In DCEMRI, there is no linear relationship between the Gd concentration and the signal intensity of the tissue. In our approximation, the transfer constant K trans is used, which represents a measure of transendothelial transport of Gd from the vessels to the tumor interstitium. 46 K trans is assumed to be indicative of the tumor's morphological features in a twofold way: (1) the image areas of interest and (2) the microcirculation.
Tumor areas defined by K trans . At first, we determine the location and space occupied by the tumor or, alternatively, the ROI. On comparing the enhancement showed in a DCEMR image by a GBM tumor mass with the neighboring healthy tissue, the former appears to be more intense due to the loss of the BBB within the majority of the tumor blood vessels and the subsequent intensified Gd efflux from the vasculature. It should be noted that the acquisition time of DCEMR images that we used in our model implementation was around five minutes in total. Given that Gd clearance can be fully attrib uted to renal excretion, the fact that Gd does not enter the cells 46 and in combination with such a short time of scanning, the visible Gd concentration can be assigned only to direct Gd exchange to and from the blood circulation in regions where blood vessels exist (and not to passive Gd diffusion).
Additionally, as already mentioned, the infiltrative nature of the edema of the GBM is confined in the peritu moral region with a small percentage of vasculature. Thus, there is limited, if any, concentration of Gd tracer in the area surrounding the tumor and no enhancement in the K trans map. 7, 8 Despite the fact that the intensity of the infiltrative edema should approximate that of the cerebrospinal fluid (CSF), this is not that clear due to the dark background of the nonaffected tissue above or below ( Fig. 1 ) within a slice. In this way, we can define the ROI from PK analysis in a DCEMR image as the enhanced area of the GBM plus the interior necrotic core. 32 Moreover, K trans is indicative of necrosis. 32 The necrotic core of the brain tumor is not expected to maintain any vessels and, thus, there is no enhancement in the MR signal intensity (SI); that is the value of K trans in that region is zero. In order to be more precise in the determination of the fraction of the ischemic necrosis, the chosen area can be set right inside after the nulls of K trans spotted in the K trans map. In other words, there is a sequence of areas with interchanged, attenuating or not, brightness. This observation was verified by a radiologist in each case.
Vasculature defined by K
trans . Angiogenic mechanisms of vascularization in GBMs result in newly formed neoplastic vessels that are leaky, tortuous, and abnormal with irregularly increased permeability, larger pores, and fluid retention prob lems. 16 The immatureness of the newly formed blood vessels may also explain the tendency of the BBB permeability. Fur thermore, Gd tracers, in contrast to oxygen (O 2 ), have a much higher molecular weight, which makes obvious that there is a need for generally more permeable vessels in order for Gd to exit from the vasculature and pass into the interstitium.
We assume (1) any vessel inside the tumor mass is highly permeable and (2) within tumor regions with the same level of oxygenation, these vessels are homogeneously allocated.
Because of the existence of many vessels, the average vessel within a voxel is expected to satisfy these assumptions. Thus, since TM itself provides no particular information about the physiology of the vessels with any impact on steric effects, ie, size of pores or diameter, we assume that the higher the Gd concentration, the more the number of vessels. In this way, the higher the K trans value, the higher the percentage of the vessels.
By incorporating this rationale into the model, there is a division of the tumor volume in regions with different levels of vasculature and, consequently, more or less effective oxy genation. It is also important to stress that K trans is a quantita tive measure and voxelspecific, with both high temporal and spatial resolution.
Having defined the necrotic (region 1 in Fig. 1C ) and the viable tumor area (region 2 in Fig. 1C , on which the K trans is used as vasculature map) from the DCEMRI GBM patient data baseline, we proceed in the next sections to initialize the predictive model.
computational Model of tumor Growth
The mathematical model used in our work 35, 36 incorporates the angiogenic cascade and oxygen supply as interacting with tumor cell populations. Depending on oxygen availability, tumor cells can be normoxic, hypoxic, or necrotic. Thus, the different components of the model are the concentrations of normoxic cells (c), hypoxic cells (h), necrotic cells (n), angio genic factors (a), endothelial cells building vasculature (v), and oxygen (o). The interacting species are described using a sys tem of partial differential equations of reactiondiffusion type (Equations 1-6).
More specifically, the model assumes that normoxic cells (Equation 1) diffuse at rate D, proliferate at rate ρ, and covert to hypoxic and necrotic cells at rates β and a n , respectively. Hypoxic cells (Equation 2) are assumed, for simplicity, to dif fuse at the same rate D and do not proliferate but can convert to normoxic cells at rate γ when oxygen becomes available. Necrotic cells (Equation 3) derive from normoxic, hypoxic, and endothelial cells that cease at a rate a n when in con tact with necrosis, as well as from hypoxic cells that turn to necrotic when oxygen is insufficient. Continuing as described in Refs 3, 6 , and Ref 35 , endothelial cells structuring vasculature (Equation 4) migrate with a diffusion rate D v , increase their population at a rate a v , and die at a rate a n . Angiogenic factors (Equation 5) diffuse with a diffusion rate D a , are produced by normoxic and hypoxic cells at rates δ c and δ h , respectively, are consumed by endothelial cells at rate q a v , decay at a rate λ, and are washed out by the vessels at a rate ω. Finally, oxygen diffuses at rate D o , decays at rate a o , is produced by vascula ture with a rate β o , and is consumed by normoxic and hypoxic cells at rates γ oc and γ oh , respectively (Equation 6). In all the equations, T is a capacity variable defined as T c h v n k = + + + , where k corresponds to the maximum capacity of a voxel, ie, the maximum number of cells it can host. ∂ ∂ = ( ) n t a h( ) a n c h v
The spatiotemporal solution of the system is approxi mated by applying the alternative direction implicit method of finite differences in three spatial dimensions. 47, 48 Neumann boundary conditions have been applied to all equations, by setting zero derivative at boundaries.
stepping from roI to discrete tumor areas. In order to initialize the populations that comprise the computational model, it is important to define the necrotic cells, discrimi nate between normoxic and hypoxic areas, and determine the density of endothelial cells within the tumor area. As already mentioned, based on K trans intensity map, the image area of necrosis (K trans = 0) and the tumor's area with viable cell popu lations (K trans ≠ 0) are defined within the ROI (regions 1 and 2 in Fig. 1C) . Thus, although necrotic cells are concentrated in areas with no K trans , hypoxic and proliferative cells are not discriminable with PK parameters. For this reason, similar to Ref. 49 , we propose a procedure to further approximate the necrotic area as well as to discriminate between normoxic and hypoxic areas.
As shown in Figure 2 , the interior core of the K trans is associated with areas of no vasculature. The areas that are nearly adjacent to the vascularized ring (intersection of the two areas) can be assumed to be marginally oxygenated and not necrotic. Therefore, in order to define the necrotic area, we erode away 10% of the K trans = 0 area (regions marked as erosion 1 in Fig. 2 ). However, it should be noted that direct use of the K trans = 0 area as necrotic region produces similar results in the simulations. In order to discriminate hypoxic and normoxic regions in the K trans ≠ 0 area, we assume that proliferative cells must have their highest density toward the periphery, 50 while the hypoxic area must be considerably larger than the normoxic ring. We consider the thickness of the nor moxic ring around the tumor surface as a variable, eroding the K trans ≠ 0 area with several different reductions. Furthermore, the density of endothelial cells was assumed to be proportional to the K trans intensity map. Model initialization and parameterization. Before feed ing the model with parameters, the system of Equations 1-6 was nondimensionalized according to previous studies. 35, 36 The length scale was set to 27.08 cm, which corresponded to the actual image size, and the time scale was set to τ = 8 hours. We rescaled cell densities with the maximum cell density, k = 10 8 cells/cm 2 , and initial vasculature and angiogenic factors with υ 0,max = 10 -2 and a max = 5.75 × 10 -4 mmol/cm 3 , respec tively. Following bibliography, 35, 36 we used the set of param eters listed in Table 1 . The effect of varying the values of these parameters has been also explored in the Results section.
Two time points of DCEMR images from a GBM patient were used in our study. The first image was used for model initialization, whereas the FU was used as a gold stan dard for validation. The original dataset consists of 37 DCE MRI slices of 192 × 192 pixels. To keep computational load low, MRI images and the respective K trans maps have been interpolated to a 96 × 96 × 96 voxel volume. Figure 3 (left) shows an exemplar slice of the initial non dimensionalized vasculature as derived from the K trans map. In the absence of any additional information, and considering that GBMs are highly diffusive brain tumors, we set the maxi mum initial concentrations of each normoxic (c 0 ), hypoxic (h 0 ), and necrotic (n 0 ) subpopulations to onethird of the maximum voxel capacity. However, we must stress that other values were tested but they did not produce sufficiently good results (data not shown). In particular, after increasing the cellularity, the simulated tumor mass appeared to be homogeneous and highly rigid, contrary to the expected heterogeneity and dif fusiveness of a real GBM tumor. Figure 3 shows the initial normoxic, hypoxic, and necrotic subpopulations. Note that there are areas that overlap between the three regions and that the peak densities are located in the periphery, the interior, and the center for normoxia, hypoxia, and necrosis, respec tively. Furthermore, erosion shrinks the periphery of necrosis by 1 mm, which can be assumed a valid maximum distance for oxygen to be transferred 51 from the K trans ≠ 0 to the K trans = 0 region. The ring of normoxic area in Figure 3 has a mean width of 1 mm. K trans is not informative regarding the levels of angio genic factors. Thus, a negligible value of the angiogenic factors was initially chosen (a 0 = 0). Indeed, we will show in the following sections that different initial values of angiogenic factors have minimal effect on tumor growth. For simplic ity, we also assumed that initially the oxygen concentra tion was set to its maximum saturation value; that is 1. It is important to mention that, at the moment studied, the tumor has generated its own blood supply and is character ized by augmented metabolism. Thus, the initial vasculature is expected to play a critical role in tumor evolution, while the need for consumption will quickly configure oxygen 
dynamics, which will further determine the distributions of normoxic, hypoxic, and necrotic subpopulations as well as angiogenic factors.
Quantitative Metrics for spatial evaluation
The resulting growth curves (cell populations over time), the similarity measurements, and a correlation analysis of the 3D volume comparing the modeling predictions and imaging data were set under study. Indicative examples/figures of 2D slices are also illustrated in Results section. For evaluation, we use a scheme that uses solid metrics and provides objective comparison. Therefore, if the final pattern of K trans is used as the golden ground truth for vasculature, we use the Jaccard (JC), Dice (DS), and Volume Similarity (VS) met rics for assessing similarity. TP (true positive) is the number of tumor voxels belong ing to both the ground truth and simulated result; FP (false positive) is the number of tumor voxels belonging to the sim ulated result but not found in ground truth; and FN (false negative) is the number of tumor voxels belonging to ground truth but not found in the simulated tumor. For eliminat ing noise and artifacts, we set the detection threshold as 10% of the maximum value for both ground truth and the test datasets.
The evaluation metrics enable comparing the vasculature of the simulated tumor and the K trans of the real FU1 tumor, concerning their volumes. A crosscorrelation analysis was made in order to further evaluate their internal transdifferen tiations beyond size.
results
Our method was applied to real patient data chosen from a nonresponder to therapy where the tumor was expanding, in order to approximate as much as possible free evolution. It is important to stress that it is hard to find patients with out resection or untreated GBM for the entire duration of the disease. In this feasibility study, data were from a patient with two time points of DCEMR images; the diagnostic and the FU clinical examinations were 39 days apart.
The clinical data used was taken from a patient with recurrent GBM, classified as stable disease using the Response Assessment in NeuroOncology (RANO) criteria, which is currently the clinical standard in the radiological FU of high grade glioma patients. The data were taken from an imaging study approved by the local ethics committee of the University Hospitals Leuven, Leuven, Belgium. The DCEMRI were acquired with a 3.0 T scanner (Achieva, Philips Medical Sys tems) using an échannel head coil for reception and the body coil for transmission.
The presence of new lesions and the generalized tumor volume progression make this case appropriate for our study. The central necrotic lesions are located in the right frontal lobe. There is extensive edema, causing mass effect on the frontal horn of the right lateral ventricle. spatial evolution of the tumor and its microenvironment. Figure 4 illustrates indicative simulation results after initializing vasculature and cell densities according to the described procedure. An analytic, quantitative evaluation of our modeling results that considers the 3D volume will be presented in the following paragraphs. An exemplar slice of the original K trans map of the FU examination, which was performed 39 days after the initial examination, is also pre sented in Figure 4 for comparison. Within the frame of Fig  ure 4 are illustrated the spatial distributions of the predicted vasculature (v) of the FU1, the normoxic (c), hypoxic (h), and necrotic (n) cell densities, as well as the angiogenic factors (a) after 39 fictitious days. The tumor increases in size, while hypoxic cells maintain the larger space within the tumor, and hypoxiadriven angiogenic factors are homogeneously allocated inside this hypoxiabounded area. The predicted vasculature (v) is similar in shape with the actual FU of the K trans map, and the model seems to qualitatively predict the hot spots of maximum abnormal vascularity (yellow to red intensity peaks). Such hot spots are usually important mark ers for the temporal therapeutic assessment and for therapy planning in general.
Vasculature predictions correlated with K trans map. The scatter plot of the K trans map of the FU1 image and the associated vasculature profile of the in silico approxima tion is shown in Figure 5 . Higher values of either K trans or vasculature density are expected at lower frequencies within a tumor mass. The calculated correlation coefficient is R = 0.8861, after truncating all zero values for K trans and v. Taken together, the evaluation results show that the two tumors are strongly correlated both in terms of size and internal characteristics.
Vasculature predictions affected by D, ρ, and the proliferative rim. This section examines the effect of a number of critical modeling parameters on the simulation result, while quantita tive metrics are used in order to better evaluate the outcome of the presented feasibility study. The first parameter studied was the diffusion coefficient D of tumor cells. Specifically, we explore how the simulated vasculature is affected when changing the diffusion rate of cells. Figure 6 shows the pre dicted spatial distribution of v for 0.1D and 10D, where D = 3.6 × 10 -8 cm 2 /s (Table 1) is within the range of values in relevant literature. 35 For comparison, Figure 6 also shows the original K trans map of the FU examination as well as the pre dicted v for the original value of D. As expected, the pattern of v for low D is highly saturated, as the inability of tumor cells to migrate fast increases their local densities and consequently their demands for new vasculature. On the other hand, higher values of D result in an increase in tumor size and produce a pattern where the vasculature seems more extended and scat tered than the original corresponding data of K trans . A quan titative comparison has been also performed and presented in the next section.
The next step is to study the effect of the proliferation rate ρ to the results. Figure 7 shows how results differ for 0.1ρ and 10ρ, where ρ = 0.0087/day (Table 1) agrees with biblio graphy values. 36, 52 The pattern of v for high ρ (ie, cells divide faster) shows a saturation of v, as increased cellular prolifera tion leads to increased tumor densities and metabolic demands that stimulate increase in vasculature. On the other hand, lower ρ produces a pattern where the vasculature seems more dispersed. Different values for both D and ρ were also tested (data not shown), but none reflected better the real FU1 than the pair of values finally chosen.
In summary, we present a quantitative evaluation of the agreement between the simulated tumor and the final tumor vasculature. Table 2 presents the resulting metrics for different cases of parameters. Metrics regarding the uniform initialization of vas culature (uniform v) is noted, since it is commonly used in the absence of relevant information. 36 The scores for uniform vascu lature are remarkably lower than the rest of the cases. Addition ally, multiple erosions with different morphological operators were tried regarding the configuration of the area of the pro liferative ring. However, this is not the case for the erosion of the necrotic core since the chosen erosion is representative of the population of cells changing between necrotic and hypoxic areas. Normoxic area diameter varied from 0 mm (no erosion) to ∼10 mm (minimum hypoxia). As can be seen in Table 2 , all metric scores are inversely proportional to the normoxic area expansion (erosions 1-5 mm show minimal differences). Alter natively, the less the assumed hypoxic region by erosion, the more inaccurate the model predictions become. According to our trials, the erosion of 1 mm appears to be the most appropri ate. The parameters used in our approximation were selected to produce the highest scores for all three evaluation metrics. temporal evolution of the tumor. Figure 8 shows the concentrations of the normoxic, hypoxic, and necrotic subpopulations over time. The total tumor population consisting of the sum of normoxic, hypoxic, and necrotic cells follows a Gompertzianlike growth, where an ini tially fast growth is followed by a slowdown phase. The normoxic subpopulation slightly decreases over time until it almost stabilizes, while hypoxic cells initially increase fast and then slow down where a plateau is r'eached. Further more, a slight increase of the necrotic population over time is also observed. As can be seen in Figure 8 , hypoxic cells dominate within the tumor, indicating that oxygen supply is insufficient for the increasing metabolic demands of tumor cells. All populations start from a nonzero value determined by the initialization process. Figure 9 shows the evolution of vasculature and angio genic factors over time. These biological phenomena are causally related; hypoxia leads to the expression of angiogenic factors, which in turn promote angiogenesis and the formation of vascu lature in hypoxic areas. Note that, a few days after hypoxic cells start increasing (Fig. 8) , both the levels of angiogenic factors and vasculature are rapidly multiplied (day 12 in Fig. 9 ). However, as hypoxic cells reach a plateau, the concentration of angiogenic factors is stabilized and vasculature keeps increasing.
As stated previously, the initial density of angiogenic factors, a 0 , was set to zero. Once again, this model param eter was checked for values other than zero: particularly, a 0 was alternatively set to the maximum value of 1. Initially, a steep drop by approximately three orders of magnitude of the angiogenic factors is observed as their consumption relative to their production is significantly higher (Fig. 10) . However, as the tumor evolves and hypoxia increases, an increase in the angiogenic factors is also observed similar to that of Fig  ure 9 (left). Interestingly, the resulting graphs of the three tumor populations and the overall tumor growth, as well as the growth of endothelial cells in time, appear to be almost the same as in Figures 8 and 9 (left). This indicates that the choice of initial a does not substantially affect the model's outcome.
discussion
This paper focuses on predicting the evolution of the GBM tumor vascularization and presents a method that, in essence, is a feasibility study toward this difficult task. Models efficiently predicting vasculature are potentially of great interest, as the evolution of tumor growth is highly determined by the evolution of its vascularization, in the context of novel treatment strategies targeting angiogen esis and therapeutic decision making as well as predicting response to treatment. DCEMRI is a plausible clinical examination, while TM is the most common approach for Gd distribution estimations; hence, the significance of translating and subsequently using DCEMRI to introduce multiple tumor development variables is evident. We presented a new way for defining the model inputs (image areas of interest and vasculature) of a glioma model by using biomarkers extracted by DCEMRI, and demonstrated that it is feasible to predict vascularity despite the complexity of the model variables (Equations 1-6) and the assumptions made. In contrast to an arbitrary initialization with homogeneous vasculature as model input, we showed that the imagingderived information regarding the initial vessel localization can yield more accurate results with respect to both tumor growth and vascularization predictions. The estimated spatial information of vasculature density within the ROI enables the model to predict intraregional differences that are closer to the ground truth. More interestingly, the method indicated that vascularity hot spot could be predicted, which in turn might be an important result for choosing the right therapy for the right patient.
Although we presented a number of qualitative and quantitative results on this study, also perturbing the param eters and the image areas of interest, the presented results need to be validated in a large number of patients in order to provide enough evidence that vasculature can be predicted with a standardized set of parameters and heuristics. In this respect, a sensitivity-specificity analysis would define a range of values within a patient database for the model parameters taken into account. 35 However, there is a difficulty in finding GBM patient data were the tumor evolution is unaffected from treatment, which renders this necessary validation hard. This repre sents a limitation of our model, since the actual therapeutic regimes (chemotherapy and radiotherapy) were not mod eled in the current version. Use of the linear quadratic (LQ ) model 20, 22 could be in the direction for simulating radiother apy, but the estimation of radiobiology parameters of the LQ is, however, the most challenging part of this task. We need to stress that, in order for this prediction method to reach the clinical setting, it will be also essential to model the effects of therapy.
An alternative prospect is to use additional imaging bio markers in order to approximate other model parameters using either other MRI techniques, PET, or magnetic resonance spectroscopic imaging (MRSI). As an example, using diffu sion MRI data, registered with the DCE MRI data, could also provide measures of cellularity to input the models.
A limitation of our method is that we oversimplified the discrimination of normoxic and hypoxic areas within the tumor. However, as a future perspective, determining these areas based on K trans and/or other PK parameter values or even additional imaging modalities can be more accurate and rep resentative of the reality. Alternatively, a control experiment could be used in order to determine the threshold value of K trans in each image area. According to this procedure, a range of values would be assigned to a given area and the ROI divi sions could be based on clustering the K trans values.
conclusion
The presented method focuses on vascularity prediction in GBM based on DCEMRI data. The open challenges for patients with GBM and brain cancer in general are to find the right way of decoding MRI scans and obtain knowledge about the specific grade, characteristics, appropriate treatment, and patient response and probability of survival, all these from the very first moment that the cancer is diagnosed. Our method, based on initializing a glioma model using DCEMRI biomarkers, indicates that the 4D profile of vas culature can be predicted especially in the sense that it can prompt the clinician to regions were vascularity will reach very high K trans values indicating tumor progression. Individ ualized predictions to monitor therapeutic effect and tumor development using computational models with noninvasive imaging biomarkers as input should be further investigated and validated, targeting direct clinical impact. This paper, however, presented a method for introducing vasculature in the modeling process, and this, if confirmed with large patient cohorts, can have a significant impact in predicting early the therapeutic effect especially with respect to tumor vascula ture change. Clearly, the lack of proper retrospective patient data and the added computational requirements for calculat ing MRIbased vasculature maps are some of the obstacles and limitations to achieve larger scale verification. However, the potential benefit in predicting vasculature response can certainly outweigh these limitations and lead to the design of proper trials, which will also take into consideration patient clinical data such as gender, weight, and comorbidities, which have an effect on the computation of PK parameters and can therefore increase accuracy.
Another potential clinically relevant implementation of our method could be the prediction of a downstaging can cer as a result of a wider variety of factors, apart from radio therapy. If this is the case, an operable GBM tumor could be identified in time, which would lead to improvement of clinical symptoms. 
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